Key facts
- It has raised $175.0M across 4 recorded rounds; the latest was PIPE ($67.0M) in Nov 2024.
- Eledon Pharmaceuticals has filed 2 Form Ds with the SEC since 2023, most recently May 2024 ($50.0M sold to 24 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Eledon Pharmaceuticals
Create free account
No card required
Funding rounds
4 roundsNov 2024PIPE$67.0M▮
Dec 2020PIPE$108.0M▮
About Eledon Pharmaceuticals
- Industry
- Other Pharmaceuticals and Biotechnology
PA Mark — not yet priced
Eledon Pharmaceuticals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Eledon Pharmaceuticals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Eledon Pharmaceuticals in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.